Multianalyte hereditary kidney cancer risk assessment panel (urine-based)
This test evaluates multiple substances in your urine to help assess your risk for hereditary kidney cancer, which may be linked to genetic mutations. It’s part of a broader evaluation for conditions like hereditary papillary renal cell carcinoma (HPRCC) or von Hippel-Lindau (VHL) disease.
["This test helps identify potential genetic predispositions that may increase your risk of kidney cancer, guiding discussions with your healthcare provider about prevention and monitoring."]
Key facts at a glance
- LOINC
- 106781-8
- Short code
- Hered renal cancer multi analy Bld/T
- Synonyms
- Hered renal cancer multi analy Bld/T
- Category
- chemistry
- Sample
- whole-blood
- Container
- Lavender-top (EDTA)
- Units
- N/A
- Critical range
- 0.5 N/A – —
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- molgen
- CPT
- 86038
- Specimen volume
- 3 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 4–24 hours
- Order
- routine
What This Test Measures
The test analyzes several urine biomarkers that may be associated with hereditary kidney cancer risk. These include substances that reflect metabolic changes, protein excretion patterns, and other molecular indicators linked to genetic mutations. The results are interpreted in the context of your medical history and family health.
Why It Might Be Ordered
Your healthcare provider may recommend this test if you have a family history of kidney cancer, certain genetic syndromes, or symptoms like unexplained weight loss, fatigue, or changes in urine appearance. It’s also used in screening for individuals at higher risk due to known hereditary conditions.
What to Expect Before the Test
No special preparation is needed for this urine test. You may be asked to collect a sample at home or bring a sample to a lab. Follow your provider’s instructions carefully to ensure accurate results.
What the Results Mean
Results will show levels of specific urine biomarkers. Elevated or abnormal levels of certain substances may suggest an increased hereditary risk, but they are not definitive diagnoses. Your provider will discuss these findings with you and may recommend further genetic testing or monitoring.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical Significance
Short name
Hereditary Kidney Cancer Risk Test (Urine)
Frequently asked questions
How does this test help with kidney cancer prevention?
What if my results are abnormal?
Can I fast before this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 17, 2026. · Read our editorial policy